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Summary of 2012 results 
 
This update presents figures from the National Drug-Related Deaths Index (NDRDI) on deaths due to poisoning by 
alcohol and/or other drugs, and deaths among drug users, in the period 2004–2012. The figures in this update 
supersede all previously published figures.
a
  
 
Overview 
• In the nine-year period 2004–2012 a total of 5,289 deaths by drug poisoning and deaths among drug users met 
the criteria for inclusion in the NDRDI database. Of these deaths, 3,112 were due to poisoning and 2,177 were 
deaths among drug users (non-poisoning) (Table 1). 
• There were 633 deaths in 2012, compared to 645 in 2011. Despite this decrease the overall trend for the 
reporting period is upwards (Table 1). The 2012 figure is likely to be revised upwards when new data become 
available. 
• Deaths due to polydrug use have increased by 60% over the reporting period from 118 in 2004 to 189 in 2012 
(Figure 3). 
 
Poisoning deaths in 2012 
• The annual number of poisoning deaths decreased from 387 in 2011 to 350 in 2012 (Table 1).    
• Males accounted for the majority of deaths in each year since 2004; 74% of all poisoning deaths in 2012 were 
male (Figure 1). 
• The median age of those who died in 2012 was 40 years, similar to previous years (Table 2). 
• Over half (54%) of all poisoning deaths in 2012 involved more than one drug (polydrug use) (Figure 3 and Table 
3).   
• Alcohol was involved in 36% of poisoning deaths in 2012, more than any other single drug (Table 5).  Alcohol 
alone was responsible for 22% of poisoning deaths in 2012, this is an increase from 17% in 2011 (Table 3). 
• Methadone was implicated in a quarter of poisonings in 2012 (Table 5). The majority of these deaths (87%) 
where methadone was implicated were polydrug poisonings. 
• Over a third (35%) of poisonings in 2012 involved benzodiazepines (Table 6).  
• The number of poisoning deaths in which heroin was implicated continues to decline with 61 deaths in 2012 
compared to 65 in 2011, a decrease of 6% (Table 5). 
• In 2012, three quarters (75%) of poisoning deaths involved alcohol and/or prescription drugs only. 
• There has been a slight decrease in the number of deaths involving antidepressants from 88 in 2011 to 77 in 
2012 (Table 7), however over the reporting period the trend is upwards. Thirteen per cent of the deaths 
involving antidepressants in 2012 had more than one antidepressant implicated. Females accounted for almost 
half (46%) of these deaths in 2012 involving antidepressants.  
• One in five (21%) poisoning deaths in 2012 involving ‘other prescription drugs’. The majority of ‘other 
prescription drugs’ were implicated in polydrug poisonings (Table 8).  
• Over a third (37%) of those who died of a poisoning death in 2012 had a history of mental illness. 
 
Non-poisoning deaths in 2012  
• The number of non-poisoning deaths recorded among drug users increased to 283, compared to 258 in 2011 
(Table 1). These deaths are categorised as being due either to trauma, or to medical causes.  
• Over a third (38%) had a history of mental illness. 
 
Deaths due to trauma 
• The number of deaths due to trauma increased in 2012 to 138 deaths from 124 in 2011, an increase of 11% 
(Figure 4).  
• The majority (100, 72%) of those who died from traumatic causes in 2012 were aged under 39 years (Figure 6). 
The median age was 29 years. As in previous years, the majority (113, 82%) of those who died due to trauma 
were male.  
                                               
a Please note that previously reported figures for the years 2004–2011 have been updated to include new data. Similarly, figures for 
2012 will be revised in the future when new data become available.  
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• The most common causes of death due to trauma in 2012 were hanging (72, 52%) and drowning (20, 14%) 
(Figure 7). 
• Over half (72, 52%) of those who died from traumatic causes in 2012 had a history of mental illness. 
 
 
Deaths due to medical causes 
• The number of deaths due to medical causes increased by 8% in 2012 to 143 deaths from 132 in 2011 (Figure 
4).  
 The majority (96, 67%) of those who died from medical causes in 2012 were aged between 35 and 59 years 
(Figure 8). The median age was 46 years. Males accounted for 70% (100) of those who died due to medical 
causes in 2012. 
• The most common medical causes of death in 2012 were cardiac events (44, 31%) and liver diseases (23, 16%) 
(Figure 9).  
 
This document may be cited as: Health Research Board (2014) Drug-related deaths and deaths among drug users in 
Ireland: 2012 figures from the National Drug-Related Deaths Index. Available at: 
www.drugsandalcohol.ie/23003 and at www.hrb.ie/publications. 
 
 
Glossary 
 
Drug users: Individuals who have a history of drug dependency or of non-dependent abuse of drugs and/or other 
substances 
 
Non-poisoning deaths: Deaths in individuals with a history of drug dependency or non-dependent abuse of drugs 
(ascertained from toxicology results and from Central Treatment List, medical or coronial records) whether or not the 
use of the drug was directly implicated in the death 
 
Poisoning deaths: Deaths which are directly due to the toxic effect of the presence in the body of one or more drugs 
and/or other substance(s) 
 
Other prescription drugs:  include non-benzodiazepine sedatives such as Z drugs (esp. Zopiclone), antipsychotics, 
antiepileptic’s, anxiety drugs and other prescription drugs. 
 
Introduction 
 
The Irish National Drug-Related Deaths Index (NDRDI) is an epidemiological database which records cases 
of death by drug and/or alcohol poisoning, and deaths among drug users and those who are alcohol dependent. The 
NDRDI is maintained by the Health Research Board (HRB). It is jointly funded by the Department of Health and the 
Department of Justice and Equality. 
 
The NDRDI was established in September 2005 to comply with Action 67 of the 2001–2008 National Drugs 
Strategy.1 Prior to that, drug-related deaths and deaths among drug users had not been systematically documented in 
Ireland.  Families of substance users in Dublin, through the National Family Support Network (which supports the 
development of family support groups and networks in Ireland in dealing with the problem of drug misuse; www.fsn.ie) 
had advocated for some years for the development of a mechanism to accurately measure the extent of premature 
death among drug users.  In response to this, Action 67 called for the development of a system for recording drug-
related deaths and deaths among drug users to enable the State and its agencies to respond in a timely manner, with 
accurate data. The objectives of the NDRDI also include identifying and prioritising areas for intervention and 
prevention, and measuring the effects of such interventions. The remit of the NDRDI was further expanded in January 
2006 to include alcohol-related deaths and deaths of people who were alcohol dependent. 
 
The number of drug-related deaths and deaths among drug users is one of the key indicators used to measure the 
consequences of problem drug use in Europe. The NDRDI enables accurate reporting of these key data to the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 
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The NDRDI records data from four sources: the Coroner Service, the Hospital In-Patient Enquiry scheme (HIPE), the 
Central Treatment List (CTL), the General Mortality Register (GMR) via the Central Statistics Office (CSO) in order to 
ensure that the database is complete and accurate. Cases from the different data sources are cross-matched on a 
selection of variables, including name, gender, county of residence, date of birth and date of death. This allows the 
NDRDI to eliminate duplicates and to maximise the amount of information available on each case recorded on the 
database. Named data were not available from the GMR for the years 2004 and 2005; to avoid duplication and over-
estimation of the number of cases, GMR cases with no match in the other three data sources were not included in the 
NDRDI for those two years. More detailed information on the methodology can be found in the previously published 
HRB Trends Series papers.2-4  
 
 
Background 
 
Drug use can lead to premature death from a range of different causes.
5
 Many deaths are caused by poisoning (both 
intentional and unintentional), where the death is directly attributable to the consumption of drugs (alone or in 
combination with other substances). For the purposes of this paper, this type of directly drug-related death is referred 
to as a poisoning. 
 
Deaths among drug users (whether the user is dependent or non-dependent) may be indirectly attributed to their drug 
use. For the purpose of this paper, this type of indirectly drug-related death is referred to as a non-poisoning. Causes of 
death in such cases include: 
 
• infection with HIV as a result of sharing drug paraphernalia, and subsequent development of an AIDS-related 
illness; 
• the harmful effects of drug use (both short and long term) on the health of the drug user, such as the 
cardio-toxic effect of cocaine or drug-related liver disease;
6-9
 
• actions taken while under the influence of drugs, such as accidents caused by impaired judgement or 
exacerbation of risky behaviours;
5, 6
 
• psychiatric illness as a co-morbid condition, which places the individual at a greater risk of suicide.5, 10-12 
 
In line with international practice, deaths that are the result of the drug use of another individual, such as a road traffic 
collision or an assault, are not recorded by the NDRDI. 
 
Alcohol consumption has been reported as the third most detrimental risk factor for ill health and premature death in 
Europe.
13
 The NDRDI has retrospectively recorded data from 2004 onwards on alcohol-related deaths and deaths 
among those who were alcohol dependent. Poisoning deaths due to alcohol-only (collected retrospectively from 2004) 
have been included in the web-updates of 2009 data onwards, therefore data reported since then differ to previous 
NDRDI reports on poisoning deaths. This update however does not include data on non-poisoning deaths in individuals 
who had a history of alcohol dependency only.  
 
Most cases of drug misuse or dependence involve illicit drugs; however, licit drugs also may be misused and may lead to 
dependency. Deaths in which licit drugs are implicated are included in the NDRDI. A documented history of drug 
dependence or drug use is not available in all cases, leading to an under recording of the total number of non-poisoning 
deaths in the drug-using population. Calculation of mortality figures for both poisonings and non-poisonings provides 
an estimate of the total burden of mortality related to drug use in Ireland. 
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Results 
 
 
Between 2004 and 2012, 5,289 deaths by drug and alcohol poisoning and deaths among drug users met the criteria for 
inclusion in the NDRDI. Please note that previously reported figures for the years 2004–2011 have been updated to 
include new data. Similarly, figures for 2012 will be revised in the future when new data become available. The NDRDI 
submits an annual report to the EMCDDA on a subset of the data on poisoning deaths which differ to the data in this 
report. For further details see the national report; http://www.drugsandalcohol.ie/php/annual_report.php 
 
 
Table 1   Number of deaths, by year, NDRDI 2004 to 2012 (N=5,289) 
  2004 2005 2006 2007 2008 2009 2010 2011 2012 
All deaths 432 505 561 626 626 656 605 645 
 
633 
 
Poisonings (3,112) 267 300 325 382 386 374 341 387 
 
350 
 
Non-poisoning 
(2,177) 
165 205 236 244 240 282 264 258 283 
 
 
 
 
 
 
 
 
 
Figure 1   Percentage poisoning deaths, by gender and by year of death, NDRDI 2004 to 2012 (N=3,112) 
 
 
 
2004 2005 2006 2007 2008 2009 2010 2011 2012
Male 65.5% 66.3% 69.5% 69.6% 71.0% 68.4% 74.2% 72.9% 74.0%
Female 34.5% 33.7% 30.5% 30.4% 29.0% 31.6% 25.8% 27.1% 26.0%
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Figure 2   Poisoning deaths, by age group, NDRDI 2012 only (N=350) 
 
 
 
Table 2   Poisoning deaths, by median age and by gender, NDRDI 2004 to 2012 (N=3,112) 
  2004 2005 2006 2007 2008 2009 2010 2011 2012 
Median age in years 40 39 36 35 38 38 40 39 40 
Age range* 20-68 18-65 20-64 19-67 21-65 22-67 21-67 22-65 22-67 
Median age-male 36 36 35 33 36 36 37 38 38 
Median age-female 47 46 43 43 46 47 49 45 49 
*Age range presented is the 5th to the 95th percentile (90% of cases are included within this range) 
 
 
 
 
 
Figure 3   Single and polydrug poisoning deaths, NDRDI 2004 to 2012 (N=3,112) 
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Table 3   Combinations of drugs involved in poisoning deaths, NDRDI 2004 to 2012 (N=3,112) 
  2004 2005 2006 2007 2008 2009 2010 2011 2012 
All poisoning deaths 267 300 325 382 386 374 341 387 350 
 
  
 
  
 
  
 
  
 
  
Single substance   
 
  
 
  
 
  
 
  
Alcohol alone 61 51 55 79 81 61 78 65 76 
Opiate alone 33 34 47 51 53 56 46 34 24 
Analgesic (inc an analgesic containing an 
opiate compound) 
22 24 15 6 10 10 7 15 19 
All other specified single substances 33 56 67 62 51 55 38 40 42 
 
         
Polysubstances   
 
  
 
  
 
  
 
  
Polysubstances including opiates (such as 
heroin, methadone) 
41 64 84 94 121 125 99 140 115 
Polysubstances including analgesics 
containing an opiate compound 
28 31 16 16 11 14 25 33 25 
Polysubstances excluding opiates 38 31 26 62 50 36 34 48 39 
Psychoactive medication with alcohol 11 9 15 12 9 17 14 12 10 
 
 
In 2009, when laboratory standards became available, we first started to see novel psychoactive substance (NPS) drugs 
being implicated in drug-related deaths. The number of deaths decreased from seven deaths involving NPS in 2011 to 5 
deaths involving NPS in 2012. The majority of these deaths involved polydrugs. NPS drugs are included in the stimulants 
drug group (Table 4). 
 
 
Table 4   Multi response drug groups, NDRDI 2004 to 2012 (N=3,111  ͌) 
  
2004 2005 2006 2007 2008 2009 2010 2011 2012 
% 
Total 
All poisoning 
deaths 267 300 325 382 386 374 341 387 350 
 
100 
 
  
 
  
 
  
 
  
 
  
 
Opiates† 131 159 182 189 218 236 191 263 220 57.5 
 
  
 
  
 
  
 
  
 
  
 
Alcohol 125 116 111 166 155 142 153 147 126 39.9 
 
  
 
  
 
  
 
  
 
  
 
Benzodiazepines 77 79 116 124 124 134 132 254 168 38.8 
 
  
 
  
 
  
 
  
 
  
 
Antidepressants 54 53 43 48 87 67 67 100 87 19.5 
 
  
 
  
 
  
 
  
 
  
 
Other prescription 
drugs§ 
42 41 39 61 62 59 74 86 97 18.0 
 
  
 
  
 
  
 
  
 
  
 
Stimulantsᵮ 32 46 61 85 67 60 28 42 40 14.8 
 
  
 
  
 
  
 
  
 
  
 
Others‡ 22 46 33 45 49 66 53 64 57 13.9 
*This is a multi-response table taking account of illicit use of up to six drugs. Therefore numbers and percentages in columns may not add up to totals        
shown as individual cases may use more than one drug or substance. 
  ͌ The cause of death in one case was multi-drug toxicity with no information on what drugs were involved thus excluded from multianalysis. 
† Includes heroin, methadone, morphine, codeine, unspecified opiate-type drug, other opiate analgesic. 
§ Includes non-benzodiazepine sedatives, anti-psychotics, Z drugs, cardiac and all other types of over-the-counter medication. 
ᵮ Includes cocaine, MDMA and Novel Psychoactive Substances. 
‡ includes solvents, insecticides, herbicides, other amphetamines, hallucinogens, cannabis, barbiturates, and other chemicals. 
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Table 5   Main specific drugs involved in poisoning deaths, NDRDI 2004 to 2012 (N=3,112)  
  
2004 2005 2006 2007 2008 2009 2010 2011 2012 
% 
Total 
All deaths* 267 300 325 382 386 374 341 387 350 100 
 
  
 
  
 
  
 
  
 
  
 
Alcohol 125 116 111 166 155 142 153 147 126 39.9 
 
  
 
  
 
  
 
  
 
  
 
Heroin 29 47 67 80 91 115 73 65 61 20.2 
Methadone 40 43 60 55 80 69 60 118 86 19.6 
 
  
 
  
 
  
 
  
 
  
 
Diazepam 31 41 64 61 66 80 68 135 87 20.3 
Flurazepam 18 13 23 21 20 24 28 50 29 7.3 
 
  
 
  
 
  
 
  
 
  
 
Cocaine 19 36 54 66 60 53 21 24 24 11.5 
MDMA 13 10 7 19 7 ͂ ͂ 11 11 2.6 
 
  
 
  
 
  
 
  
 
  
 Citalopram 13 12 7 13 19 20 19 31 21 4.9 
 
  
 
  
 
  
 
  
 
  
 
Zopiclone 5 ͂ 7 6 10 12 18 22 22 3.3 
 
  
 
  
 
  
 
  
 
  
 
Olanzapine ͂ ͂ ͂ 9 9 8 14 10 22 2.6 
*This is a multi-response table taking account of illicit use of up to six drugs. Therefore numbers and percentages in columns may not add up to totals 
shown as individual cases may use more than one drug or substance. 
~ Less than five cases. 
 
 
 
 
Of the 123 individual deaths in 2012 in which benzodiazepines were implicated, 40 cases involved two or more types of 
benzodiazepine (Table 6). However, the total count for all benzodiazepines in the multi-response table is equal to 168 
(Table 4). 
 
Table 6   Total number of deaths where any benzodiazepine was implicated, NDRDI 2004 to 2012 (N=934)    
  2004 2005 2006 2007 2008 2009 2010 2011 2012 
All NDRDI poisonings 267 300 325 382 386 374 341 387 350 
 
  
 
  
 
  
 
  
 
  
Individual deaths 
where BZD implicated 
(% of all poisonings) 
64  
(24) 
65 
(21.7) 
91 
(28) 
97 
(25.4) 
103 
(26.7) 
113 
(30.2) 
105 
(30.8) 
173 
(44.7) 
123 
(35.1) 
 
  
 
  
 
  
 
  
 
  
Poly drugs involved 61 64 88 96 103 112 105 170 121 
 
  
 
  
 
  
 
  
 
  
More than one BZD 
implicated 
13 11 21 23 19 21 25 70 40 
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Of the 77 individual deaths in 2012 in which antidepressants were implicated, 10 deaths involved more than one type 
of antidepressants (Table 7). The total count for all antidepressants in the multi-response table is equal to 87 (Table 4). 
Citalopram is the most common antidepressant implicated in these deaths and was implicated in over a quarter (21, 
27.3%) of individual deaths involving antidepressants in 2012 (Table 5). 
 
Table 7   Total number of deaths where any antidepressant was implicated, NDRDI 2004 to 2012 (N=539) 
  2004 2005 2006 2007 2008 2009 2010 2011 2012 
All NDRDI poisonings 267 300 325 382 386 374 341 387 350 
 
  
 
  
 
  
 
  
 
  
Individual deaths 
where antidepressants 
implicated (% of all 
poisonings) 
46 
 (17.2) 
46 
(15.3) 
40 
(12.3) 
46 
 (12) 
76 
(19.7) 
59 
(15.8) 
61  
(17.9) 
88 
(22.7) 
77  
(22) 
 
  
 
  
 
  
 
  
 
  
Poly drugs involved 42 35 32 40 63 48 52 81 66 
 
  
 
  
 
  
 
  
 
  
More than one 
antidepressant 
implicated 
8 7 ~ ~ 10 5 5 11 10 
 
 
‘Other prescription drugs’ were implicated in 21% of poisoning deaths in 2012, the majority (60, 81%) involved polydrug 
poisonings (Table 8). Antipsychotic drugs contributed to 29 (39.2%) of these deaths and the main drug implicated in 
these deaths involving antipsychotic drugs was Olanzapine (22, 75.9) (Table 5).  
 
Z-drugs were implicated in 27 (36.5%) of individual deaths involving other prescription drugs, Zopiclone being the main 
Z-drug, implicated in 22 (81.5%) of deaths involving Z-drugs in 2012 (Table 5). 
 
 
Table 8   Individual deaths involving ‘other prescription drugs’, NDRDI 2004 to 2012 (N=459) 
  2004 2005 2006 2007 2008 2009 2010 2011 2012 
All NDRDI poisonings 267 300 325 382 386 374 341 387 350 
 
  
 
  
 
  
 
  
 
  
Individual deaths where 
‘other prescription drugs’ 
implicated (% of all 
poisonings) 
35 
(13.1) 
33 
(11) 
37 
(11.4) 
47 
(12.3) 
56 
(14.5) 
46 
(12.3) 
60 
(17.6) 
71 
(18.3) 
74 
(21.1) 
 
  
 
  
 
  
 
  
 
  
of which involved:   
 
  
 
  
 
  
 
  
     -  Antipsychotic drugs 6 ~ ~ 14 11 11 17 22 29 
 
  
 
  
 
  
 
  
 
  
     -  Z - drugs 10 6 13 7 14 14 24 31 27 
 
  
 
  
 
  
 
  
 
  
Poly drugs involved 27 23 23 39 50 41 52 68 60 
 
  
 
  
 
  
 
  
 
  
More than one 'other 
prescription drugs' involved 
5 5 ~ 8 6 8 12 13 21 
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Table 9   Poisoning deaths by place of residence, by drugs task force area, NDRDI 2004 to 2012 (N=3,112)  
  2004 2005 2006 2007 2008 2009 2010 2011 2012 
South East RDTF 26 23 22 39 40 33 37 34 42 
North Eastern  RDTF 18 20 25 27 29 22 23 44 30 
Southern  RDTF 19 22 21 30 31 24 19 37 27 
Cork LDTF 14 12 20 27 13 19 14 10 23 
North Inner City LDTF 14 18 13 14 24 19 21 30 20 
Mid-West  RDTF 15 18 13 18 19 37 29 25 19 
South Western  RDTF 11 14 17 19 23 19 24 25 18 
North West  RDTF 14 13 10 8 13 17 7 11 18 
Western  RDTF 17 19 17 33 23 23 21 19 17 
Midlands  RDTF 12 15 17 17 21 26 19 26 14 
Dublin North East LDTF 9 10 25 19 16 10 7 10 14 
Tallaght LDTF 7 7 9 5 8 15 11 9 14 
North Dublin City and 
County  RDTF 10 14 12 15 12 20 20 20 13 
Dublin South Inner City LDTF 7 8 19 21 13 13 11 20 13 
Dun Laoghaire-Rathdown 
LDTF 16 13 16 17 14 13 19 6 11 
Finglas-Cabra LDTF ~ 9 6 6 12 10 7 6 10 
Clondalkin LDTF 9 10 6 ~ 9 6 6 5 6 
East Coast  RDTF 6 19 11 10 11 ~ 12 8 ~ 
Ballyfermot LDTF 5 ~ 7 6 7 ~ ~ ~ ~ 
Blanchardstown LDTF ~ 5 5 ~ 5 ~ ~ 6 ~ 
Canal Communities LDTF ~ ~ ~ ~ ~ ~ ~ ~ ~ 
Bray LDTF ~ ~ ~ ~ ~ ~ ~ ~ ~ 
Ballymun LDTF 8 6 10 5 7 10 5 6 ~ 
Dublin 12 LDTF 11 6 ~ 9 11 ~ ~ ~ ~ 
Other/unknown 8 11 18 26 19 18 13 18 16 
~ Less than five cases. 
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Non-poisoning deaths 
 
Of the 2,177 non-poisoning deaths in the period 2004–2012, the category of death was known for 2,092 (96%), of which 
1,089 were due to traumatic causes and 1,003 were due to medical causes.  These figures do not include deaths among 
alcohol-dependent people who were not drug users.  
 
 
 
Figure 4   Non-poisoning deaths among drug users, NDRDI 2004 to 2012 (N=2,092) 
 
 
 
 
 
 
Figure 5   Non-Poisoning deaths among drug users, by history of mental illness, NDRDI 2010 to 2012 
(N=804) 
 
 
 
 
 
 
 
2004 2005 2006 2007 2008 2009 2010 2011 2012
Medical 55 68 105 114 121 132 133 132 143
Trauma 92 118 124 120 112 136 125 124 138
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Deaths due to trauma 
 
 
 
 
Figure 6    Deaths among drug users due to trauma, by age group, NDRDI 2012 only (N=138) 
 
 
 
 
 
Figure 7   Deaths among drug users due to trauma, by main type of death, NDRDI 2004 to 2012 (N=1089) 
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Deaths due to medical causes 
 
 
 
 
Figure 8   Deaths among drug users due to medical causes, by age group, NDRDI 2012 only (N=143) 
 
 
 
 
 
 
 
Figure 9   Deaths among drug users due to medical causes, by main type, NDRDI 2004 to 2012 (N=1,003) 
 
 
 
 
 
 
  
0
5
10
15
20
25
30
15 - 24 25 - 29 30 - 34 35 - 39 40 - 44 45 - 49 50 - 54 55 - 59 60 - 64 >=65
N
u
m
b
e
r 
0
5
10
15
20
25
30
35
40
45
50
2004 2005 2006 2007 2008 2009 2010 2011 2012
N
u
m
b
e
r 
Cardiac
Respiratory
Liver diseases
13 
 
References 
 
1. Department of Tourism Sport and Recreation (2001) Building on experience: National Drugs Strategy 2001–2008. 
Dublin: Stationery Office. 
2. Lynn E, Lyons S, Walsh S and Long J (2009) Trends in deaths among drug users in Ireland from traumatic and medical 
causes, 1998 to 2005. HRB Trends Series 8. Dublin: Health Research Board. 
3. Lyons S, Lynn E, Walsh S and Long J (2008) Trends in drug-related deaths and deaths among drug users in Ireland, 
1998 to 2005. HRB Trends Series 4. Dublin: Health Research Board. 
4. Bellerose D, Lyons S, Carew AM, Walsh S and Long J (2010) Problem benzodiazepine use in Ireland: treatment (2003 
to 2008) and deaths (1998 to 2007). HRB Trends Series 9. Dublin: Health Research Board. 
5. Darke S, Degenhardt L and Mattick R (2007) Mortality amongst illicit drug users: epidemiology, causes and 
intervention. Cambridge: Cambridge University Press. 
6. Webb L, Oyefeso A, Schifano F, Cheeta S, Pollard M and Ghodse HA (2003) Cause and manner of death in drug-
related fatality: an analysis of drug-related deaths recorded by coroners in England and Wales in 2000. Drug and 
Alcohol Dependence, 72(1): 67–74. 
7. Darke S, Kaye S and Duflou J (2004) Cocaine-related fatalities in New South Wales, Australia 1993–2002. Drug and 
Alcohol Dependence, 77(2): 107–114. 
8. Quaglio G, Talamini G, Lechi A, Venturini L, Lugoboni F, Mezzelani P (2001) Study of 2708 heroin-related deaths in 
north-eastern Italy 1985–98 to establish the main causes of death. Addiction, 96(6): 1127–1137. 
9. Karch S (2002) Karch's pathology of drug abuse. 3rd edition. Boca Raton, FL: CRC Press. 
10. Baldacchino A and Corkery J (2006) Comorbidity: perspectives across Europe. London: European Collaborating 
Centres in Addition Studies. 
11. Darke S, Duflou J and Torok M (2009) Toxicology and circumstances of completed suicide by means other than 
overdose. Journal of Forensic Sciences, 54(2): 490–494. 
12. Farrell M, Neeleman J, Griffiths P and Strang J (1996) Suicide and overdose among opiate addicts. Addiction, 91(3): 
321–323. 
13. WHO (2002) The world health report 2002: reducing risks, promoting healthy life. Geneva: World Health 
Organization.  
 
Acknowledgements 
 
The NDRDI would like to express sincere thanks to all those who contribute to the NDRDI, in particular NDRDI staff, the 
staff of the Coroner Service, Forensic and Legal Medicine UCD, HIPE, CSO and CTL.  We also would like to thank the CSO 
for their assistance in the provision of data and for facilitating NDRDI's access to the data.  All the co-operation and 
assistance is very much appreciated and valued.   
 
For further information on the NDRDI please contact Ena Lynn (01 2345155), Suzi Lyons (01 2345163) or ndrdi@hrb.ie. 
 
